<p>The drug semaglutide, typically prescribed for treatment of Type 2 diabetes, was used in a phase 3 clinical trial as a treatment for obesity with very promising results. Northwestern's Robert Kushner, MD, led this study, recently published in the <em>New England Journal of Medicine</em> and shares the results.</p>

The drug semaglutide, typically prescribed for treatment of Type 2 diabetes, was used in a phase 3 clinical trial as a treatment for obesity with very promising results. Northwestern's Robert Kushner, MD, led this study, recently published in the New England Journal of Medicine and shares the results.

A Promising Obesity Drug with Robert Kushner, MD

Breakthroughs is a podcast about groundbreaking research and the scientists leading these discoveries at Northwestern University Feinberg School of Medicine. We are driven by our mission to transform the practice of medicine and profoundly impact human health beyond the individual patient. We believe better answers only come from discovery.

Share A Promising Obesity Drug with Robert Kushner, MD

Sign up to save your podcasts

A Promising Obesity Drug with Robert Kushner, MD

A Promising Obesity Drug with Robert Kushner, MD

More shows like Breakthroughs

On the Media

The Insightful Leader

Freakonomics Radio

Hidden Brain

The New Yorker Radio Hour

Pod Save America

NorthwesternU

One Book, One Northwestern: The Podcast

Northwestern Intersections

Why Is This Happening? The Chris Hayes Podcast

The Peter Attia Drive

The Megyn Kelly Show

Huberman Lab

The Ezra Klein Show

We Can Do Hard Things

The Weekly Show with Jon Stewart

Explore Global Health with Rob Murphy, MD

Letters from an American

The Wirecutter Show